SCHEMBL16319803

SCHEMBL16319803

COc1ccc(Cl)cc1Oc1cc(F)c(C#N)cc1F

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 3/20 0.44
SLC22A12 Q96S37 8/20 0.43
S1PR3 Q99500 3/20 0.43
EGFR P00533 1/20 0.41
ERBB2 P04626 1/20 0.41
SRC P12931 1/20 0.41
SLC6A2 P23975 2/20 0.39
KCNH2 Q12809 2/20 0.39
SLC6A3 Q01959 1/20 0.39
AR P10275 1/20 0.39
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 2/20 0.39
USP2 O75604 1/20 0.39
MEN1 O00255 1/20 0.39
HPGD P15428 1/20 0.39
KMT2A Q03164 1/20 0.39
S1PR1 P21453 1/20 0.38
PRKCQ Q04759 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL365037 0.86 SLC22A12 (0.48) SLC22A12ARKDM4EALDH1A1USP2
SCHEMBL16319488 0.84 SLC22A12 (0.39) SLC6A4SLC22A12S1PR3EGFRERBB2
SCHEMBL16319403 0.81 EPAS1 (0.38) SLC6A4SLC22A12SLC6A2KCNH2AR
SCHEMBL16319786 0.81 AR (0.45) SLC22A12EGFRERBB2ARKDM4E
SCHEMBL16319638 0.80 SLC22A12 (0.48) SLC22A12EGFRERBB2ARKDM4E
SCHEMBL16319451 0.79 AR (0.46) SLC22A12ARKDM4EALDH1A1USP2
SCHEMBL11963120 0.78 TRPV4 (0.50) SLC22A12ARKDM4EALDH1A1USP2
SCHEMBL16174914 0.77 SLC22A12 (0.43) SLC6A4SLC22A12SLC6A2ARALDH1A1
SCHEMBL16319665 0.76 ESRRA (0.47) SLC6A4SLC22A12EGFRERBB2SLC6A2
SCHEMBL16319445 0.74 SLC6A2 (0.49) SLC6A4SLC6A2SLC6A3KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593427-B1 SULFONAMIDE DERIVATIVES AS NAV1.7 INHIBITORS FOR THE TREATMENT OF PAIN PFIZER LTD (GB) 2014-12-24 EP disclosed